MitoFit Open Seminars: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
Laner Verena (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
== 2018-06-15 08:30 Friday MiPArt science meeting == | == 2018-06-15 08:30 Friday MiPArt science meeting == | ||
::::* [[Schmitt S |Dr. Sabine Schmitt]], Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München: Impact of tigecyclin on mitochondrial respiration, H2O2 production, ATP production and membrane potential. (Final report [[MtFOIE GRAS]] secondment. | ::::* [[Schmitt S |Dr. Sabine Schmitt]], Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München: Impact of tigecyclin on mitochondrial respiration, H2O2 production, ATP production and membrane potential. (Final report [[MtFOIE GRAS]] secondment.) | ||
::::* Carolina Doerrier, Erich Gnaiger: Update on SUIT protocols and DL7 | ::::* Carolina Doerrier, Erich Gnaiger: Update on SUIT protocols and DL7 | ||
Revision as of 15:17, 3 July 2018
MitoFit Open Seminars
2018-06-15 08:30 Friday MiPArt science meeting
- Dr. Sabine Schmitt, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München: Impact of tigecyclin on mitochondrial respiration, H2O2 production, ATP production and membrane potential. (Final report MtFOIE GRAS secondment.)
- Carolina Doerrier, Erich Gnaiger: Update on SUIT protocols and DL7
